These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 33309227)
1. A mysterious surge of aspergillosis among non-SARS-CoV-2 patients during COVID-19 pandemic. Lai CC; Chen CM; Liao KM; Chao CM; Chan KS; Yu WL J Microbiol Immunol Infect; 2021 Feb; 54(1):156-158. PubMed ID: 33309227 [No Abstract] [Full Text] [Related]
2. COVID-Associated Pulmonary Aspergillosis in the United States: Is It Rare or Have We Missed the Diagnosis? Zhang SX; Balada-Llasat JM; Pancholi P; Sullivan KV; Riedel S; J Clin Microbiol; 2021 Sep; 59(10):e0113521. PubMed ID: 34288730 [No Abstract] [Full Text] [Related]
3. COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges. Prattes J; Koehler P; Hoenigl M; Intensive Care Med; 2021 Nov; 47(11):1339-1340. PubMed ID: 34468820 [No Abstract] [Full Text] [Related]
4. The Challenge of Managing COVID-19 Associated Pulmonary Aspergillosis. Brüggemann RJ; van de Veerdonk FL; Verweij PE Clin Infect Dis; 2021 Dec; 73(11):e3615-e3616. PubMed ID: 32810202 [No Abstract] [Full Text] [Related]
5. A rare case report of tracheobronchial aspergillosis with endobronchial aspergilloma in a patient clinically recovered from COVID-19. Rai DK; Kumar S Indian J Pathol Microbiol; 2022; 65(3):713-715. PubMed ID: 35900511 [TBL] [Abstract][Full Text] [Related]
6. COVID-19-Associated Pulmonary Aspergillosis at an Academic Medical Center in the Midwestern United States. Wasylyshyn AI; Wasylyshyn GR; Linder KA; Miceli MH Mycopathologia; 2021 Aug; 186(4):499-505. PubMed ID: 34143393 [TBL] [Abstract][Full Text] [Related]
13. COVID-19-Associated Pulmonary Aspergillosis in a Series of Complete Autopsies from the Brazilian Amazon. Farias ME; Santana MF; Ferreira L; Borba M; Silva-Neto J; Brito-Sousa JD; Baía-da-Silva DC; João GP; Val F; Simão M; Souza JV; Naveca F; Melo G; Monteiro W; Lacerda M Am J Trop Med Hyg; 2022 Jan; 106(2):571-573. PubMed ID: 34996046 [TBL] [Abstract][Full Text] [Related]
14. Emerging Success Against the COVID-19 Pandemic: Hospital Surge Capacity in Taiwan. Wang TY; Liu HL; Lin CY; Kuo FL; Yang PH; Yeh IJ Ann Emerg Med; 2020 Sep; 76(3):374-376. PubMed ID: 32828337 [No Abstract] [Full Text] [Related]
15. Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19). Dupont D; Menotti J; Turc J; Miossec C; Wallet F; Richard JC; Argaud L; Paulus S; Wallon M; Ader F; Persat F Med Mycol; 2021 Jan; 59(1):110-114. PubMed ID: 32914189 [TBL] [Abstract][Full Text] [Related]
16. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series. Flikweert AW; Grootenboers MJJH; Yick DCY; du Mée AWF; van der Meer NJM; Rettig TCD; Kant MKM J Crit Care; 2020 Oct; 59():149-155. PubMed ID: 32674001 [TBL] [Abstract][Full Text] [Related]
17. Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient. Blaize M; Mayaux J; Nabet C; Lampros A; Marcelin AG; Thellier M; Piarroux R; Demoule A; Fekkar A Emerg Infect Dis; 2020 Jul; 26(7):1636-1637. PubMed ID: 32343223 [TBL] [Abstract][Full Text] [Related]
19. A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab. Cai S; Sun W; Li M; Dong L Clin Rheumatol; 2020 Sep; 39(9):2797-2802. PubMed ID: 32562070 [TBL] [Abstract][Full Text] [Related]
20. Coronavirus Disease 2019-associated Pulmonary Aspergillosis: Do We Have the CAPAcity to Improve Outcomes? Baddley JW Clin Infect Dis; 2022 Jan; 74(1):92-94. PubMed ID: 33754152 [No Abstract] [Full Text] [Related] [Next] [New Search]